N-Methylated arginines such as asymmetric dimethyl-L-arginine (ADMA) and monomethyl-L-arginine(NMMA) are known as potent physiological inhibitors of nitric oxide synthases (NOSs). To explore apossible physiological and pharmaceutical relevance of Nta.gif" BORDER=0 >-methylated analogues, a synthetic schemehad to be developed that would not lead to Nta.gif" BORDER=0 >-methyl-L-arginine only but also to its presumed metabolitesof NOS catalysis. Two basic synthetic approaches have been pursued to obtain Nta.gif" BORDER=0 >-methylated derivativesof L-ornithine, L-citrulline, L-arginine, and N-hydroxy-L-arginine. A first attempt utilized conventionallyprotected L-ornithine, i.e., the tert-butyl ester and Boc-amine, and led to three end compounds in excellentyields. Simultaneous protection of the -amino acid moiety by formation of boroxazolidinones, particularlyby employing 9-borabicyclo[3.3.1]nonane (9-BBN-H), proved to be a convenient option to perform sidechain modifications and led to all of the desired end compounds. Additionally, enantiomeric excess (ee,%) of crucial synthetic intermediates and end compounds was determined by chiral HPLC.